1. Alemtuzumab linked with serious and potentially fatal ADRs

   News item 04 July 2020 Pages: 1 - 1

2. EMA issues recommendations on impurities in medicines

   News item 04 July 2020 Pages: 2 - 2

3. Health Canada: risk of VTE with tofacitinib and ruxolitinib

   News item 04 July 2020 Pages: 3 - 3

4. Vincristine labelling changed to prevent fatal medication errors

   News item 04 July 2020 Pages: 4 - 4

5. Project Patient Voice records cancer symptoms and side effects

   News item 04 July 2020 Pages: 5 - 5

6. AEs with high- and standard-dose influenza vaccine in ESRD

   Clinical study 04 July 2020 Pages: 6 - 6

7. Benzodiazepines, hypnosedatives may increase risk of preterm birth

   Clinical study 04 July 2020 Pages: 7 - 7

8. Musculoskeletal surgery bleeding with HES vs albumin

   Clinical study 04 July 2020 Pages: 8 - 8

9. Postmarketing surveillance of acute kidney injury with PPIs

   Clinical study 04 July 2020 Pages: 9 - 9

10. Prescription sequence symmetry analysis for signal detection

    Clinical study 04 July 2020 Pages: 10 - 10

11. Subdeltoid bursitis associated with IM influenza vaccine

    Clinical study 04 July 2020 Pages: 11 - 11

12. Other adverse reaction research

    News item 04 July 2020 Pages: 12 - 12

13. Acitretin/colchicine/prednisolone

    Case report 04 July 2020 Pages: 13 - 13

14. Adalimumab

    Case report 04 July 2020 Pages: 14 - 14

15. Adalimumab

    Case report 04 July 2020 Pages: 15 - 15

16. Adalimumab/azathioprine

    Case report 04 July 2020 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 04 July 2020 Pages: 17 - 17

18. Adenosine

    Case report 04 July 2020 Pages: 18 - 18

19. Alectinib/ceritinib/crizotinib

    Case report 04 July 2020 Pages: 19 - 19

20. Alendronic acid/deflazacort

    Case report 04 July 2020 Pages: 20 - 20

21. Alirocumab/metformin/valsartan

    Case report 04 July 2020 Pages: 21 - 21

22. Alprazolam

    Case report 04 July 2020 Pages: 22 - 22

23. Alteplase/heparin/low-molecular-weight-heparins

    Case report 04 July 2020 Pages: 23 - 23

24. Amikacin/imipenem/cilastatin/levofloxacin

    Case report 04 July 2020 Pages: 24 - 24

25. Amiodarone

    Case report 04 July 2020 Pages: 25 - 25

26. Amiodarone/bisoprolol/landiolol

    Case report 04 July 2020 Pages: 26 - 26

27. Amiodarone/warfarin interaction

    Case report 04 July 2020 Pages: 27 - 27

28. Amoxicillin

    Case report 04 July 2020 Pages: 28 - 28

29. Anastrozole

    Case report 04 July 2020 Pages: 29 - 29

30. Anlotinib/icotinib/pembrolizumab

    Case report 04 July 2020 Pages: 30 - 30

31. Antibacterials

    Case report 04 July 2020 Pages: 31 - 31

32. Antibacterials/parenteral nutrition supplements

    Case report 04 July 2020 Pages: 32 - 32

33. Antibacterials/unspecified corticosteroids

    Case report 04 July 2020 Pages: 33 - 33

34. Anticoagulants/aspirin

    Case report 04 July 2020 Pages: 34 - 34

35. Anticoagulants/clopidogrel/ticagrelor

    Case report 04 July 2020 Pages: 35 - 35

36. Antiepileptic-drugs/barbiturates

    Case report 04 July 2020 Pages: 36 - 36

37. Antihaemorrhagics

    Case report 04 July 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 04 July 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 04 July 2020 Pages: 39 - 39

40. Antineoplastics

    Case report 04 July 2020 Pages: 40 - 40

41. Antineoplastics

    Case report 04 July 2020 Pages: 41 - 41

42. Antineoplastics

    Case report 04 July 2020 Pages: 42 - 42

43. Antineoplastics

    Case report 04 July 2020 Pages: 43 - 43

44. Antineoplastics

    Case report 04 July 2020 Pages: 44 - 44

45. Antineoplastics

    Case report 04 July 2020 Pages: 45 - 45

46. Antineoplastics

    Case report 04 July 2020 Pages: 46 - 46

47. Antineoplastics/antithymocyte-globulin

    Case report 04 July 2020 Pages: 47 - 47

48. Antipsychotics

    Case report 04 July 2020 Pages: 48 - 48

49. Antiretrovirals

    Case report 04 July 2020 Pages: 49 - 49

50. Antiretrovirals

    Case report 04 July 2020 Pages: 50 - 50